These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8239938)

  • 1. Quality of laboratory performance in testing for human immunodeficiency virus type 1 antibody. Identification of variables associated with laboratory performance.
    Hancock JS; Taylor RN; Johnson CA; Gerber AR; Schalla WO
    Arch Pathol Lab Med; 1993 Nov; 117(11):1148-55. PubMed ID: 8239938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of laboratory performance in testing for human immunodeficiency virus type 1 antibody. Variables associated in multivariate analyses.
    Gerber AR; Valdiserri RO; Johnson CA; Schwartz RE; Hancock JS; Hearn TL
    Arch Pathol Lab Med; 1991 Nov; 115(11):1091-6. PubMed ID: 1747026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytic sensitivity and specificity of enzyme immunoassay results in testing for human immunodeficiency virus type 1 antibody.
    Cross GD; Schalla WO; Hancock JS; Hearn TL; Blumer SO; Taylor RN; Valdiserri RO
    Arch Pathol Lab Med; 1992 May; 116(5):477-81. PubMed ID: 1580749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Centers for Disease Control perspective on quality assurance for human immunodeficiency virus type 1 antibody testing. Model Performance Evaluation Program.
    Valdiserri RO; Taylor RN; Hearn TL; Schalla WO; Muir HW
    Arch Pathol Lab Med; 1990 Mar; 114(3):263-7. PubMed ID: 2154961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of quality control on accuracy in enzyme immunoassay testing for human immunodeficiency virus type 1 antibodies.
    Astles JR; Lipman HB; Schalla WO; Blumer SO; Fehd RJ; Smith C; Hearn TL
    Arch Pathol Lab Med; 1998 Aug; 122(8):700-7. PubMed ID: 9701331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T-lymphotropic virus type I/II. Status of enzyme immunoassay and western blot testing in the United States in 1989 and 1990.
    Blumer SO; Hearn TL; Schalla WO; Cross GD; Valdiserri RO
    Arch Pathol Lab Med; 1992 May; 116(5):471-6. PubMed ID: 1316110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpretive criteria used to report western blot results for HIV-1-antibody testing--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1991 Oct; 40(40):692-5. PubMed ID: 1656186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytic results of HIV-1 testing using blind proficiency testing.
    Peddecord KM; Benenson AS; Hofherr LK; Francis DP; Garfein RS; Ferran KL; Taylor RN; Schalla WO; Ascher MS
    Clin Lab Sci; 1992; 5(3):165-71. PubMed ID: 10147724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDC's Model Performance Evaluation Program: assessment of the quality of laboratory performance for HIV-1 antibody testing.
    Schalla WO; Hearn TL; Taylor RN; Eavenson E; Valdiserri RO; Essien JD
    Public Health Rep; 1990; 105(2):167-71. PubMed ID: 2157234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of an alternative supplemental testing strategy for HIV diagnosis by retrospective analysis of clinical HIV testing data.
    Styer LM; Sullivan TJ; Parker MM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S35-40. PubMed ID: 22018662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for acute human immunodeficiency virus infection in Baltimore public testing sites.
    Temkin E; Marsiglia VC; Hague C; Erbelding E
    Sex Transm Dis; 2011 May; 38(5):374-7. PubMed ID: 21183865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Could saliva be used to detect HIV seroconversion?].
    Sangaré KA; Koffi AR; Coulibaly IM; Doulourou C
    Sante; 1997; 7(5):303-7. PubMed ID: 9480036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the impact of a CD4+ T-cell testing laboratory improvement program.
    Rosner E; Siragusa M; Schalla W; Cross D; Cohn R; Hearn T
    Arch Pathol Lab Med; 1998 Jun; 122(6):512-9. PubMed ID: 9625418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of anti-HIV-1 IgG antibodies in whole saliva by GACELISA and Western blot assays.
    Matee MI; Lyamuya EF; Simon E; Mbena EC; Kagoma C; Samaranayake LP; Scheutz F
    East Afr Med J; 1996 May; 73(5):292-4. PubMed ID: 8756029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WHO international quality assessment scheme for HIV antibody testing: results from the second distribution of sera.
    Snell JJ; Supran EM; Tamashiro H
    Bull World Health Organ; 1992; 70(5):605-13. PubMed ID: 1464146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the implementation of HIV-rapid test kits at different levels of health institutions in Ethiopia.
    Tegbaru B; Wolday D; Messele T; Meless H; Kassa D; Tesema D; Tamene W; Ahmedin Z; Adane A; Tebeje M; Gezahegn N; Birhanu H; Mengistu Y; Wuhib T; Fekadu M
    Ethiop Med J; 2007 Jul; 45(3):293-9. PubMed ID: 18330330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for human immunodeficiency virus antibody in urine.
    Berrios DC; Avins AL; Haynes-Sanstad K; Eversley R; Woods WJ
    Arch Pathol Lab Med; 1995 Feb; 119(2):139-41. PubMed ID: 7848060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of nonanalytic issues in HIV-1 antibody testing using blind proficiency testing.
    Peddecord KM; Benenson AS; Hofherr LK; Garfein RS; Francis DP; Hewitt DJ; Ferran KL; Schalla WO; Hearn TL
    Clin Lab Sci; 1992; 5(3):172-6. PubMed ID: 10147725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of testing and potential impact on HIV prevention in Nigeria.
    Odaibo GN; Donbraye E; Adewumi MO; Bakarey AS; Ibeh MA; Olaleye DO
    Afr J Med Med Sci; 2006 Dec; 35 Suppl():131-5. PubMed ID: 18050787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Would CLSI M53-A have helped in the diagnosis of HIV in Canada? Results of the performance of Canadian laboratories participating in a recent NLHRS proficiency testing panel containing HIV-1 antigen positive (antibody negative) and HIV-2 samples.
    Kadivar K; Malloch L; Adonsou-Hoyi Y; Ng D; Lavoie S; Pulido K; Kim J
    J Clin Virol; 2013 Sep; 58(1):303-5. PubMed ID: 23890809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.